Slide background
Slide background
Slide background
Slide background
Slide background

Phyton Biotech is the world’s first and only company to harness plant cell fermentation (PCF®) technology for development and commercialization of plant-derived pharmaceuticals.  Phyton’s scalable and environmentally responsible PCF platform has resulted in high-value commercial oncology actives and scalable expression systems for complex plant-based molecules for pharmaceutical development.

 Phyton Biotech is the world’s largest commercial provider of high quality Paclitaxel and Docetaxel API via PCF®

and we proudly call many of the world’s leading injectables companies our customers. 

With GMP facilities near Hamburg and Vancouver, Phyton also provides a broad range of

development services for plant-based actives and other complex molecules.

Transparent box

Development Services

Phyton offers world class development services for complex small molecules and for plant-based actives and recombinant proteins using PCF® technology.      

Commercial Products

Phyton is the world’s largest producer of Paclitaxel and Docetaxel via PCF®. Our APIs do not rely on problematic yew tree derived 10-DAB.

Quality & Regulatory

Phyton’s APIs are USP/EP grade, under CEPs and DMFs, and manufactured under strict GMP control from starting material through to finished API.

Transparent box